Adverse drug reaction profiles of histone deacetylase inhibitors. [PDF]
Begum R, Parsons JL, Jones AM.
europepmc +1 more source
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment. [PDF]
Macrì E +4 more
europepmc +1 more source
HDAC inhibitors as anticancer drugs: chemical diversity, clinical trials, challenges and perspectives. [PDF]
Abdallah AE.
europepmc +1 more source
Applications of Sombor topological indices and entropy measures for QSPR modeling of anticancer drugs: a Python-based methodology. [PDF]
Kara Y +3 more
europepmc +1 more source
Reversing Bladder Cancer Chemo-resistance through Blocking Cell Senescence by a Combination Therapy. [PDF]
He Y +11 more
europepmc +1 more source
Anticancer activity of sodium propionate in hepatocellular carcinoma cells via downregulation of HDAC2 and HDAC6. [PDF]
Yadav GP +6 more
europepmc +1 more source
CFGSCDSA: Predicting circRNA-drug sensitivity associations based on collaborative feature learning and graph structure learning. [PDF]
Zhang X, Zou Q, Wang C, Niu M.
europepmc +1 more source
Correction: <i>In Vitro</i> BBB triculture assay and preliminary computational model development to predict brain exposure. [PDF]
Xu ZM, Sluka JP, Zhang CC, Knipp G.
europepmc +1 more source
An Integrated Approach of Proteomic, Cheminformatic, and In Vitro Drug Screening to Identify Potential Therapeutic Targets of <i>Taenia solium</i> Cysticerci Proteases. [PDF]
Kaur R +9 more
europepmc +1 more source
Epigenetic and mitoepigenetic regulation in cancer and therapeutic perspectives. [PDF]
Celik-Uzuner S +3 more
europepmc +1 more source

